From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

BREAKING: Email Exchange with Steve O’Hara about that share sale yesterday & new price target for Optibiotix

By Tom Winnifrith | Tuesday 1 August 2023


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I discussed Optibiotix (OPTI) selling 3% of Skinbiotherapeutics (SBTX) in bearcast yesterday HERE. As a result of the disposal I have cut my target for Optibiotix from 82p to 78p but the cash position is enhanced so it is de-risked. But I am pissed off, not least with the way broker Cenkos behaved. I think Cenkos should be fired. Here is how the conversation between Cenkos and O’Hara went ( I imagine):
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 12:51:12